4,436
Views
37
CrossRef citations to date
0
Altmetric
Research Paper

IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation

, , , , , , & show all
Pages 406-413 | Published online: 20 Jun 2012

References

  • Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 2007; 449:804 - 10; http://dx.doi.org/10.1038/nature06244; PMID: 17943116
  • Gosalbes MJ, Durbán A, Pignatelli M, Abellan JJ, Jiménez-Hernández N, Pérez-Cobas AE, et al. Metatranscriptomic approach to analyze the functional human gut microbiota. PLoS One 2011; 6:e17447; http://dx.doi.org/10.1371/journal.pone.0017447; PMID: 21408168
  • Jarchum I, Pamer EG. Regulation of innate and adaptive immunity by the commensal microbiota. Curr Opin Immunol 2011; 23:353 - 60; http://dx.doi.org/10.1016/j.coi.2011.03.001; PMID: 21466955
  • Benson AK, Kelly SA, Legge R, Ma F, Low SJ, Kim J, et al. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci U S A 2010; 107:18933 - 8; http://dx.doi.org/10.1073/pnas.1007028107; PMID: 20937875
  • Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453:620 - 5; http://dx.doi.org/10.1038/nature07008; PMID: 18509436
  • Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature 2009; 457:480 - 4; http://dx.doi.org/10.1038/nature07540; PMID: 19043404
  • Maccaferri S, Biagi E, Brigidi P. Metagenomics: key to human gut microbiota. Dig Dis 2011; 29:525 - 30; http://dx.doi.org/10.1159/000332966; PMID: 22179207
  • Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130:1480 - 91; http://dx.doi.org/10.1053/j.gastro.2005.11.061; PMID: 16678561
  • Codling C, O’Mahony L, Shanahan F, Quigley EM, Marchesi JR. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci 2010; 55:392 - 7; http://dx.doi.org/10.1007/s10620-009-0934-x; PMID: 19693670
  • Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100:373 - 82; http://dx.doi.org/10.1111/j.1572-0241.2005.40312.x; PMID: 15667495
  • Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133:24 - 33; http://dx.doi.org/10.1053/j.gastro.2007.04.005; PMID: 17631127
  • Kerckhoffs AP, Samsom M, van der Rest ME, de Vogel J, Knol J, Ben-Amor K, et al. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 2009; 15:2887 - 92; http://dx.doi.org/10.3748/wjg.15.2887; PMID: 19533811
  • Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 2010; 22:512 - 9, e114-5; PMID: 19903265
  • Rajilić-Stojanović M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011; 141:1792 - 801; http://dx.doi.org/10.1053/j.gastro.2011.07.043; PMID: 21820992
  • Marteau P. Probiotics in functional intestinal disorders and IBS: proof of action and dissecting the multiple mechanisms. Gut 2010; 59:285 - 6; http://dx.doi.org/10.1136/gut.2008.173690; PMID: 20207630
  • Spiller R. Review article: probiotics and prebiotics in irritable bowel syndrome. Aliment Pharmacol Ther 2008; 28:385 - 96; http://dx.doi.org/10.1111/j.1365-2036.2008.03750.x; PMID: 18532993
  • Simrén M, Ohman L, Olsson J, Svensson U, Ohlson K, Posserud I, et al. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study. Aliment Pharmacol Ther 2010; 31:218 - 27; PMID: 19863495
  • Søndergaard B, Olsson J, Ohlson K, Svensson U, Bytzer P, Ekesbo R. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial. Scand J Gastroenterol 2011; 46:663 - 72; http://dx.doi.org/10.3109/00365521.2011.565066; PMID: 21443416
  • Maccaferri S, Klinder A, Brigidi P, Cavina P, Costabile A. Potential probiotic Kluyveromyces marxianus B0399 modulates the immune response in Caco-2 cells and peripheral blood mononuclear cells and impacts the human gut microbiota in an in vitro colonic model system. Appl Environ Microbiol 2012; 78:956 - 64; http://dx.doi.org/10.1128/AEM.06385-11; PMID: 22156412
  • Candela M, Consolandi C, Severgnini M, Biagi E, Castiglioni B, Vitali B, et al. High taxonomic level fingerprint of the human intestinal microbiota by ligase detection reaction--universal array approach. BMC Microbiol 2010; 10:116; http://dx.doi.org/10.1186/1471-2180-10-116; PMID: 20398430
  • Castiglioni B, Rizzi E, Frosini A, Sivonen K, Rajaniemi P, Rantala A, et al. Development of a universal microarray based on the ligation detection reaction and 16S rrna gene polymorphism to target diversity of cyanobacteria. Appl Environ Microbiol 2004; 70:7161 - 72; http://dx.doi.org/10.1128/AEM.70.12.7161-7172.2004; PMID: 15574913
  • Rajilić-Stojanović M, Smidt H, de Vos WM. Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol 2007; 9:2125 - 36; http://dx.doi.org/10.1111/j.1462-2920.2007.01369.x; PMID: 17686012
  • Hamady M, Knight R. Microbial community profiling for human microbiome projects: Tools, techniques, and challenges. Genome Res 2009; 19:1141 - 52; http://dx.doi.org/10.1101/gr.085464.108; PMID: 19383763
  • Lisotti A, Cornia GL, Morselli-Labate AM, Sartini A, Turco L, Grasso V, et al. Effects of a fermented milk containing Kluyveromyces marxianus B0399 and Bifidobacterium lactis Bb12 in patients with irritable bowel syndrome. Minerva Gastroenterol Dietol 2011; 57 (Suppl. 1 n.2):1-12.
  • Salonen A, de Vos WM, Palva A. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 2010; 156:3205 - 15; http://dx.doi.org/10.1099/mic.0.043257-0; PMID: 20705664
  • Ringel Y, Ringel-Kulka T. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome. J Clin Gastroenterol 2011; 45:Suppl S145 - 8; http://dx.doi.org/10.1097/MCG.0b013e31822d32d3; PMID: 21992954
  • Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes?. Nat Rev Immunol 2010; 10:735 - 44; http://dx.doi.org/10.1038/nri2850; PMID: 20865020
  • Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010; 90:859 - 904; http://dx.doi.org/10.1152/physrev.00045.2009; PMID: 20664075
  • Wallace TC, Guarner F, Madsen K, Cabana MD, Gibson G, Hentges E, et al. Human gut microbiota and its relationship to health and disease. Nutr Rev 2011; 69:392 - 403; http://dx.doi.org/10.1111/j.1753-4887.2011.00402.x; PMID: 21729093
  • Wassenaar TM, Klein G. Safety aspects and implications of regulation of probiotic bacteria in food and food supplements. J Food Prot 2008; 71:1734 - 41; PMID: 18724773
  • Michail S, Kenche H. Gut microbiota is not modified by randomized, double-blind, placebo-controlled trial of VSL#3 in diarrhea-predominant Irritable Bowel Syndrome. Probiotics Antimicrob Proteins 2011; 3:1 - 7; http://dx.doi.org/10.1007/s12602-010-9059-y; PMID: 22247743
  • Larsen N, Vogensen FK, Gøbel R, Michaelsen KF, Abu Al-Soud W, Sørensen SJ, et al. Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07. FEMS Microbiol Ecol 2011; 75:482 - 96; http://dx.doi.org/10.1111/j.1574-6941.2010.01024.x; PMID: 21204871
  • Vitali B, Ndagijimana M, Cruciani F, Carnevali P, Candela M, Guerzoni ME, et al. Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol 2010; 10:4; http://dx.doi.org/10.1186/1471-2180-10-4; PMID: 20055983
  • Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 2010; 5:e10667; http://dx.doi.org/10.1371/journal.pone.0010667; PMID: 20498852
  • Maccaferri S, Vitali B, Klinder A, Kolida S, Ndagijimana M, Laghi L, et al. Rifaximin modulates the colonic microbiota of patients with Crohn’s disease: an in vitro approach using a continuous culture colonic model system. J Antimicrob Chemother 2010; 65:2556 - 65; http://dx.doi.org/10.1093/jac/dkq345; PMID: 20852272
  • Magurran A. Measuring biological diversity. Oxford: Blackwell Publishing; 2004.
  • Cocolin L, Bisson LF, Mills DA. Direct profiling of the yeast dynamics in wine fermentations. FEMS Microbiol Lett 2000; 189:81 - 7; http://dx.doi.org/10.1111/j.1574-6968.2000.tb09210.x; PMID: 10913870

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.